AQ-101

CAS No. 1353384-61-8

AQ-101( AQ101 )

Catalog No. M11437 CAS No. 1353384-61-8

AQ-101 is a novel small-molecule anthraquinone analog that induces MDM2 protein degradation (Kd=0.37 uM) through a self-ubiquitination and proteasome-mediated mechanism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AQ-101
  • Note
    Research use only, not for human use.
  • Brief Description
    AQ-101 is a novel small-molecule anthraquinone analog that induces MDM2 protein degradation (Kd=0.37 uM) through a self-ubiquitination and proteasome-mediated mechanism.
  • Description
    AQ-101 is a novel small-molecule anthraquinone analog that induces MDM2 protein degradation (Kd=0.37 uM) through a self-ubiquitination and proteasome-mediated mechanism, leading to activation of p53; induces apoptosis of acute lymphoblastic leukemia (ALL) especially those with a wild-type p53 phenotype and MDM2 expression in vitro and in vivo; inhibits development of ALL in nude or SCID mice with a human ALL xenograft.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AQ101
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    MDM2-p53
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1353384-61-8
  • Formula Weight
    331.708
  • Molecular Formula
    C16H10ClNO5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(C=C1C2=O)=CC(O)=C1C(C3=C2C=CC=C3O)=O)CCl
  • Chemical Name
    2-chloro-N-(4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gu L, et al. Mol Cancer Ther. 2018 Feb;17(2):497-507.
molnova catalog
related products
  • RO-5353

    A potent, selective, and orally active p53-MDM2 antagonist with IC50 of 7 nM.

  • RDR03871

    RDR03871 is an MDM2 inhibitor.

  • NSC-66811

    A potent, MDM2-p53 interaction inhibitor with Ki of 120 nM, activates p53 in cancer cells.